Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J William Lindsey

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Medical Genetics. Part A|April 6, 2005
Familial recurrence rates and genetic models of multiple sclerosisJ William Lindsey
Journal of Neuroimmunology|August 6, 2017
Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteinsJ William Lindsey
Multiple Sclerosis and Related Disorders|November 28, 2025
Epstein-Barr virus and multiple sclerosis: A mechanism comes into focusJ William Lindsey
Journal of Neuroimmunology|September 10, 2010
Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivityJ William Lindsey, Landon M Hatfield
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 28, 2019
Tumefactive demyelination: Clinical outcomes, lesion evolution and treatmentsStaley A Brod, J William Lindsey, Flavia Nelson
Multiple Sclerosis and Related Disorders|January 5, 2023
The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatmentH Phuong T Pham, Sepideh Saroukhani, J William Lindsey
Molecular Medicine (Cambridge, Mass.)|October 1, 2010
Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cellsJ William Lindsey, Sandeep K Agarwal, Filemon K Tan
Neurology|May 23, 2008
Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosisJ William Lindsey, Michael P Crawford, Landon M Hatfield
Multiple Sclerosis and Related Disorders|October 8, 2021
The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatmentH Phuong T Pham, Resmi Gupta, J William Lindsey
Molecular Immunology|December 7, 2015
Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein LJ William Lindsey, Samantha L deGannes, Kimberly A Pate, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Medical Genetics. Part A|April 6, 2005
Familial recurrence rates and genetic models of multiple sclerosisJ William Lindsey
Journal of Neuroimmunology|August 6, 2017
Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteinsJ William Lindsey
Multiple Sclerosis and Related Disorders|November 28, 2025
Epstein-Barr virus and multiple sclerosis: A mechanism comes into focusJ William Lindsey
Journal of Neuroimmunology|September 10, 2010
Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivityJ William Lindsey, Landon M Hatfield
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 28, 2019
Tumefactive demyelination: Clinical outcomes, lesion evolution and treatmentsStaley A Brod, J William Lindsey, Flavia Nelson
Multiple Sclerosis and Related Disorders|January 5, 2023
The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatmentH Phuong T Pham, Sepideh Saroukhani, J William Lindsey
Molecular Medicine (Cambridge, Mass.)|October 1, 2010
Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cellsJ William Lindsey, Sandeep K Agarwal, Filemon K Tan
Neurology|May 23, 2008
Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosisJ William Lindsey, Michael P Crawford, Landon M Hatfield
Multiple Sclerosis and Related Disorders|October 8, 2021
The cellular immune response against Epstein-Barr virus decreases during ocrelizumab treatmentH Phuong T Pham, Resmi Gupta, J William Lindsey
Molecular Immunology|December 7, 2015
Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein LJ William Lindsey, Samantha L deGannes, Kimberly A Pate, et al.
Pageof 2